Belicia Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 M
as on 10-12-2024
- Revenue 11.13%
(FY 2022)
- Profit 37.33%
(FY 2022)
- Ebitda -87.30%
(FY 2022)
- Net Worth 54.04%
(FY 2022)
- Total Assets 38.56%
(FY 2022)
About Belicia Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajeev Dwivedi, Uttam Dutta, Vishal Srivastava, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85191UP2016PTC076181
- Company No.
076181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Belicia Lifesciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uttam Dutta  | Director | 01-Feb-2016 | Current |
| Rajeev Dwivedi | Director | 01-Feb-2016 | Current |
| Vishal Srivastava | Director | 01-Feb-2016 | Current |
| Sandeep Sharma | Director | 01-Feb-2016 | Current |
| Vikas Bajpai | Additional Director | 02-Apr-2018 | Current |
Financial Performance of Belicia Lifesciences.
Belicia Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.13% increase. The company also saw a substantial improvement in profitability, with a 37.33% increase in profit. The company's net worth Soared by an impressive increase of 54.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Belicia Lifesciences?
In 2019, Belicia Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
United Bank Of India Creation Date: 20 Apr 2018 | ₹1.00 M | Satisfied |
How Many Employees Work at Belicia Lifesciences?
Unlock and access historical data on people associated with Belicia Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Belicia Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Belicia Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
